Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Early Access to Medicines Scheme: Overview
Lillys triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial
VSMC phenotypic switching is characterized by transformation from a quiescent contractile to an activated synthetic phenotype, promoting proliferation and leading to the formation of the neointima, the pathological vascular compartment critical for the development of atherosclerosis
INTRODUCTION Gahete et al
US$ 29.18
US$ 24.82
US$ 27.62
US$ 25.63
